Corrigendum to:Ceftriaxone-induced immune hemolytic anemia[Ann Pharmacother, (2014), 48, 1594-1604, 10.1177/1060028014548310];Ceftriaxone-Induced Immune Hemolytic Anemia

Annals of Pharmacotherapy

Volumn 48, Issue 12, 2014, Pages 1594-1604

  Neuman, Gal ^a,c   Boodhan, Sabrina ^a,c   Wurman, Ilana ^b   Koren, Gideon ^a,c   Bitnun, Ari ^a,c   Kirby Allen, Melanie ^a,c   Ito, Shinya ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

adverse drug reactions; ceftriaxone; ceftriaxone induced immune hemolytic anemia; cephalosporins; drug induced immune hemolytic anemia; sickle cell disease

Indexed keywords

CEFTRIAXONE; DEXAMETHASONE; ERYTHROMYCIN; LACTATE DEHYDROGENASE; MEROPENEM; METHYLPREDNISOLONE; OSELTAMIVIR; VANCOMYCIN; ANTIINFECTIVE AGENT; AUTOANTIBODY;

ACUTE CHEST SYNDROME; ACUTE KIDNEY FAILURE; ADD ON THERAPY; ANEMIA; AUTOIMMUNE HEMOLYTIC ANEMIA; BACTERIAL PNEUMONIA; CANADA; CASE REPORT; CHILD; DATA BASE; DRUG EXPOSURE; DRUG INDUCED DISEASE; EARLY DIAGNOSIS; EMBASE; GROUPS BY AGE; HEMOGLOBINURIA; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; IMMUNOASSAY; INFLUENZA A; MALE; MEDLINE; MORTALITY; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; BLOOD; CHEMICALLY INDUCED; COMPLICATION; IMMUNOLOGY; RESPIRATORY TRACT INFECTIONS; SICKLE CELL ANEMIA;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANEMIA, SICKLE CELL; ANTI-BACTERIAL AGENTS; AUTOANTIBODIES; CEFTRIAXONE; CHILD; HUMANS; MALE; RESPIRATORY TRACT INFECTIONS;

EID: 84921451811     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028015580345     Document Type: Erratum

References (50)

1. Garratty G.Drug-induced immune haemolytic anaemia.Hematology Am Soc Hematol Educ Program. 2009;:73-79
2. Arndt PA,Leger RM,Garratty G.Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune haemolytic anaemia.Transfusion. 2012;52:602-612
3. Seltsam A,Salama A.Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature.Intensive Care Med. 2000;26:1390-1394
4. Bell MJ,Stockwell DC,Luban NLC, et al.Ceftriaxone-induced haemolytic anaemia and hepatitis in an adolescent with haemoglobin SC disease.Pediatr Crit Care Med. 2005;6:363-366
5. Health Canada. Ceftriaxone (Rocephin) and immune haemolytic anaemia in children. http://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/carn-bcei_v15n1-eng.php#a6. Accessed October 15, 2013.
6. US Food and Drug Administration. Ceftriaxone for injection and dextrose injection in the duplex container: detailed view. Safety labeling changes approved by FDA Center for Drug Evaluation and Research (CDER), June2010. http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm218869.htm. Accessed October 15, 2013.
7. Baskin MN,Goh XL,Heeney MM,Harper MB.Bacteremia risk and outpatient management of febrile patients with sickle cell disease.Pediatrics. 2013;131:1035-1041
8. Naranjo CA,Busto U,Sellers EM, et al.A method for estimating the probability of adverse drug reactions.Clin Pharmacol Ther. 1981;30:239-245
9. Moher D,Liberati A,Tetzlaff J,Altman DG.Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.PLoS Med. 2009;6:e1000097
10. Garratty G,Postoway N,Schwellenbach J,McMahill PC.A fatal case of ceftriaxone (Rocephin)-induced haemolytic anaemia associated with intravascular immune haemolysis.Transfusion. 1991;31:176-179
11. Longo F,Hastier P,Buckley MJ,Chichmanian RM,Delmont JP.Acute hepatitis, autoimmune haemolytic anaemia, and erythroblastocytopenia induced by ceftriaxone.Am J Gastroenterol. 1998;93:836-837
12. Maraspin V,Lotric-Furlan S,Strle F.Ceftriaxone associated haemolysis.Wien Klin Wochenschr. 1999;111:368-370
13. Punar M,Özsüt H,Eraksoy H,Çalangu S,Dilmener M.An adult case of fatal haemolysis induced by ceftriaxone.Clin Microbiol Infect. 1999;5:585-586
14. Falezza GC,Piccoli PL,Franchini M,Gandini G,Aprili G.Ceftriaxone-induced haemolysis in an adult.Transfusion. 2000;40:1543-1545
15. Seltsam A,Salama A.Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature.Intensive Care Med. 2000;26:1390-1394
16. Williams CS,Shamdas GJ,Thornhill TS,Baron JM.A fatal case of ceftriaxone-induced autoimmune haemolytic anaemia.Hosp Physician. 2009; (July/August): 21-25
17. Kim S,Song KS,Kim HO,Lee HM.Ceftriaxone induced immune haemolytic anaemia: detection of drug-dependent antibody by ex-vivo antigen in urine.Yonsei Med J. 2002;43:391-394
18. Dinesh D,Dugan N,Carter J.Intravascular haemolysis in a patient on ceftriaxone with demonstration of anticeftriaxone antibodies.Intern Med J. 2008;38:438-441
19. Imam SN,Wright K,Bhoopalam N,Choudhury A.Haemolytic anaemia from ceftriaxone in an elderly patient: a case report.J Am Med Dir Assoc. 2008;9:610-611
20. Ye W,Liu C-W.A case of ceftriaxone-induced haemolysis complicated by acute portal vein thrombosis.Chin Med J (Engl). 2011;124:152-154
21. Kapur G,Valentini RP,Mattoo TK,Warrier I,Imam AA.Ceftriaxone induced haemolysis complicated by acute renal failure.Pediatr Blood Cancer. 2008;50:139-142
22. Quillen K,Lane C,Hu E,Pelton S,Bateman S.Prevalence of ceftriaxone-induced red blood cell antibodies in paediatric patients with sickle cell disease and human immunodeficiency virus infection.Pediatr Infect Dis J. 2008;27:357-358
23. Doratotaj S,Recht M,Garratty G,Krupicka M,Thomas GA,Boshkov L.Successful treatment of life-threatening ceftriaxone-induced haemolysis by plasmapheresis in a 4-year old girl.Transfusion. 2009;49 (S-020B): 13A-14A
24. Schuettpelz LG,Behrens D,Goldsmith MI,Druley TE.Severe ceftriaxone-induced haemolysis complicated by diffuse cerebral ischemia in a child with sickle cell disease.J Pediatr Hematol Oncol. 2009;31:870-872
25. Döneray H,Yıldırım ZK,Büyükavcı M,Orbak Z.Seftriaksonla ilişkili hemolitik anemi: Bir vaka takdimi.Çocuk Sağlığı ve Hastalıkları Dergisi. 2009;52:154-158
26. Tobian AAR,Shirey RS,Savage WJ.Transfusion med illustrated: ceftriaxone-induced acute haemolytic anaemia.Transfusion. 2010;50:1647-1648
27. Al-Hawsawi ZM,Turkistani WA,Al-Aidaros MA,Al-Harbi DL.Ceftriaxone induced acute multi-organ failure syndrome in a Saudi boy with sickle cell disease.Saudi Med J. 2010;31:826-828
28. Boggs SR,Cunnion KM,Raafat RH.Ceftriaxone-induced haemolysis in a child with Lyme arthritis: a case for antimicrobial stewardship.Pediatrics. 2011;128:e1289-1292
29. Reis Boto ML,Sandes AR,Brites A,Silva S,Stone R,Almeida M.Severe immune haemolytic anaemia due to ceftriaxone in a patient with congenital nephrotic syndrome.Acta Paediatr. 2011;100:e191-e193
30. Goyal M,Donoghue A,Schwab S,Hasbrouck N,Khojasteh S,Osterhoudt K.Severe haemolytic crisis after ceftriaxone administration.Pediatr Emerg Care. 2011;27:322-323
31. Bernini JC,Mustafa MM,Sutor LJ,Buchanan GR.Fatal haemolysis induced by ceftriaxone in a child with sickle cell anaemia.J Pediatr. 1995;126 (5, pt 1): 813-815
32. Borgna-Pignatti C,Bezzi TM,Reverberi R.Fatal ceftriaxone-induced haemolysis in a child with acquired immunodeficiency syndrome.Pediatr Infect Dis J. 1995;14:1116-1117
33. Lascari AD,Amyot K.Fatal haemolysis caused by ceftriaxone.J Pediatr. 1995;126 (5, pt 1): 816-817
34. Scimeca PG,Weinblatt ME,Boxer R.Haemolysis after treatment with ceftriaxone.J Pediatr. 1996;128 (1): 163
35. Moallem HJ,Garratty G,Wakeham M, et al.Ceftriaxone-related fatal haemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection.J Pediatr. 1998;133:279-281
36. Viner Y,Hashkes PJ,Yakubova R,Segal-Kupershmit D,Luder AS.Severe haemolysis induced by ceftriaxone in a child with sickle-cell anaemia.Pediatr Infect Dis J. 2000;19:83-85
37. Citak A,Garratty G,Ucsel R,Karabocuoglu M,Uzel N.Ceftriaxone-induced haemolytic anaemia in a child with no immune deficiency or haematological disease.J Paediatr Child Health. 2002;38:209-210
38. Grossjohann B,Eichler P,Greinacher A,Santoso S,Kroll H.Ceftriaxone causes drug-induced immune thrombocytopenia and haemolytic anaemia: characterization of targets on platelets and red blood cells.Transfusion. 2004;44:1033-1040
39. Kakaiya R,Cseri J,Smith S,Silberman S,Rubinas TC,Hoffstadter A.A case of acute haemolysis after ceftriaxone: immune complex mechanism demonstrated by flow cytometry.Arch Pathol Lab Med. 2004;128:905-907
40. Mattis LE,Saavedra JM,Shan H,Shirey RS,Powell E,Oliva-Hemker MM.Life-threatening ceftriaxone-induced immune haemolytic anaemia in a child with Crohn’s disease.Clin Pediatr (Phila). 2004;43:175-178
41. Demirkaya E,Atay AA,Musabak U,Sengul A,Gok F.Ceftriaxone-related haemolysis and acute renal failure.Pediatr Nephrol. 2006;21:733-736
42. Candemir M,Polat A,Kılıç İ,Balcı YI,İnan M,Halis H.Sefalosporinlerle ilişkili otoimmün hemolitik anemi: Bir vaka takdimi.Çocuk Sağlığı ve Hastalıkları Dergisi. 2006;49:315-318
43. Arndt PA,Leger RM,Garratty G.Serology of antibodies to second- and third-generation cephalosporins associated with immune haemolytic anaemia and/or positive direct antiglobulin tests.Transfusion. 1999;39:1239-1246
44. Garratty G.Immune haemolytic anaemia associated with drug therapy.Blood Rev. 2010;24:143-150
45. Garratty G.Immune haemolytic anaemia caused by drugs.Expert Opin Drug Saf. 2012;11:635-642
46. Salama A.Drug-induced immune haemolytic anaemia.Expert Opin Drug Saf. 2009;8:73-79
47. Arndt PA,Garratty G.The changing spectrum of drug-induced immune haemolytic anaemia.Semin Hematol. 2005;42:137-144
48. Tschudy KM,Arcara KMThe Harriet Lane Handbook. 19th ed.St Louis, MO: Mosby; 2012.St Louis, MO: Mosby; 2012:
49. Petz LD,Garratty GImmune Haemolytic Anaemias. 2nd ed.Philadelphia, PA: Churchill Livingstone; 2004.Philadelphia, PA: Churchill Livingstone; 2004:
50. Garratty G.Review: drug-induced immune haemolytic anaemia: the last decade.Immunohematology. 2004;20:138-146